Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 35 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Vyzantiadis, Timoleon-Achilleas  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Ioakimidou, A., Vyzantiadis T-A., Tragiannidis A., Arabatzis M., Papageorgiou T., Velegraki A., et al. (2011).  Candida hellenica var. hellenica as a possible cause of respiratory infection in a child with acute myeloid leukemia.. Med Mycol. 49(7), 771-4.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 1963-1972.
Theodoridou, S., Balassopoulou A., Boutou E., Delaki E-E., Yfanti E., Vyzantiadis T-A., et al. (2020).  Coinheritance of Triplicated Alpha-Globin Gene and Beta-Thalassemia Mutations in Adulthood: Ten Years of Referrals in Northern Greece.. J Pediatr Hematol Oncol. 42(8), e762-e764.
Markantonatou, A-M., Samaras K., Zachrou E., & Vyzantiadis T-A. (2020).  Comparison of Four Methods for the Susceptibility Testing of Dermatophytes.. Front Microbiol. 11, 1593.
Theodoridou, S., Teli A., Yfanti E., Vyzantiadis T-A., Theodoridis T., & Economou M. (2018).  Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling.. Hemoglobin. 42(2), 129-131.
Theodoridou, S., Vyzantiadis T-A., & Vlachaki E. (2018).  Compound Heterozygosity for Silent Cap +1570 (T>C) (HBB: c*96T>C), Codon 39 (C>T) (HBB: c.118C>T) and the Presence of ααα/αα in Greece. A Case Presentation.. Hemoglobin. 42(3), 194-195.
Papadopoulou, A., Alvanou M., Koukoulias K., Athanasiou E., Lazaridou A., Savvopoulos N., et al. (2019).  Correction to: Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.. Bone Marrow Transplant. 54(12), 2120.
E
Anagnostis, P., Vyzantiadis T-A., Charizopoulou M., Adamidou F., Karras S., Goulis D. G., et al. (2013).  The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.. Thromb Haemost. 110(2), 257-63.
Chatzivasileiou, K., Kotsiomiti E., & Vyzantiadis T-A. (2019).  Effectiveness of Denture Cleansers on Removal of Adherent Candida albicans Cells from Denture Base Acrylics of Various Roughness.. Int J Prosthodont. 32(2), 196-197.
Bouziana, S., Tziomalos K., Goulas A., Vyzantiadis T-A., Papadopoulou M., Panderi A., et al. (2019).  Effects of major adipokines and the -420 C > G resistin gene polymorphism on the long-term outcome of patients with acute ischemic stroke.. Int J Neurosci. 129(10), 978-985.
Kourtidou, C., Rafailidis V., Varouktsi G., Kanakis E., Liakopoulos V., Vyzantiadis T-A., et al. (2023).  Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage.. J Pers Med. 13(3), 
Theodoridou, S., Prapas N., Balassopoulou A., Boutou E., Vyzantiadis T-A., Adamidou D., et al. (2018).  Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.. Hemoglobin. 42(4), 257-263.
Kourtidou, C., Rafailidis V., Varouktsi G., Kanakis E., Liakopoulos V., Vyzantiadis T-A., et al. (2022).  Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population.. J Pers Med. 12(7), 

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.